Sho Hanakawa
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sho Hanakawa.
Nature Immunology | 2014
Yohei Natsuaki; Gyohei Egawa; Satoshi Nakamizo; Sachiko Ono; Sho Hanakawa; Takaharu Okada; Nobuhiro Kusuba; Atsushi Otsuka; Akihiko Kitoh; Tetsuya Honda; Saeko Nakajima; Soken Tsuchiya; Yukihiko Sugimoto; Ken J. Ishii; Hiroko Tsutsui; Hideo Yagita; Yoichiro Iwakura; Masato Kubo; Lai guan Ng; Takashi Hashimoto; Judilyn Fuentes; Emma Guttman-Yassky; Yoshiki Miyachi; Kenji Kabashima
It remains largely unclear how antigen-presenting cells (APCs) encounter effector or memory T cells efficiently in the periphery. Here we used a mouse contact hypersensitivity (CHS) model to show that upon epicutaneous antigen challenge, dendritic cells (DCs) formed clusters with effector T cells in dermal perivascular areas to promote in situ proliferation and activation of skin T cells in a manner dependent on antigen and the integrin LFA-1. We found that DCs accumulated in perivascular areas and that DC clustering was abrogated by depletion of macrophages. Treatment with interleukin 1α (IL-1α) induced production of the chemokine CXCL2 by dermal macrophages, and DC clustering was suppressed by blockade of either the receptor for IL-1 (IL-1R) or the receptor for CXCL2 (CXCR2). Our findings suggest that the dermal leukocyte cluster is an essential structure for elicitating acquired cutaneous immunity.
Journal of Investigative Dermatology | 2014
Saeko Nakajima; Akihiko Kitoh; Gyohei Egawa; Yohei Natsuaki; Satoshi Nakamizo; Catharina Sagita Moniaga; Atsushi Otsuka; Tetsuya Honda; Sho Hanakawa; Wataru Amano; Yoichiro Iwakura; Susumu Nakae; Masato Kubo; Yoshiki Miyachi; Kenji Kabashima
Atopic dermatitis (AD) is generally regarded as a type 2 helper T (Th2)-mediated inflammatory skin disease. Although the number of IL-17A-producing cells is increased in the peripheral blood and in acute skin lesion of AD patients, the role of IL-17A in the pathogenesis of AD remains unclear. To clarify this issue, we used murine AD models in an IL-17A-deficient condition. In a repeated hapten application-induced AD model, skin inflammation, IL-4 production in the draining lymph nodes (LNs), and hapten-specific IgG1 and IgE induction were suppressed in IL-17A-deficient mice. Vγ4(+) γδ T cells in the skin-draining LNs and Vγ5(-) dermal γδ T cells in the skin were the major sources of IL-17A. Consistently, in flaky-tail (Flg(ft/ft) ma/ma) mice, spontaneous development of AD-like dermatitis and IgE induction were attenuated by IL-17A deficiency. Moreover, Th2 differentiation from naive T cells was promoted in vitro by the addition of IL-17A. Taken together, our results suggest that IL-17A mediates Th2-type immune responses and that IL-17A signal may be a therapeutic target of AD.
Nature Communications | 2013
Atsushi Otsuka; Saeko Nakajima; Masato Kubo; Gyohei Egawa; Tetsuya Honda; Akihiko Kitoh; Takashi Nomura; Sho Hanakawa; Catharina Sagita Moniaga; Bongju Kim; Satoshi Matsuoka; Takeshi Watanabe; Yoshiki Miyachi; Kenji Kabashima
The relative contributions of basophils and dendritic cells in Th2 skewing to foreign antigen exposure remain unclear. Here we report the ability of basophils to induce Th2 polarization upon epicutaneous sensitization with different antigens using basophil conditionally depleted Bas TRECK transgenic mice. Basophils are responsible for Th2 skewing to haptens and peptide antigens, but not protein antigens in vivo. Consistent with this, basophils cannot take up or process ovalbumin protein in significant quantities, but present ovalbumin peptide to T cells for Th2 differentiation via major histocompatibility complex class II. Intriguingly, basophils promote Th2 skewing upon ovalbumin protein exposure in the presence of dendritic cells. Taken together, our results suggest that basophils alone are able to induce Th2 skewing with haptens and peptide antigens but require dendritic cells for the induction of Th2 for protein antigens upon epicutaneous immunization.
Journal of Experimental Medicine | 2015
Yu Sawada; Tetsuya Honda; Sho Hanakawa; Satoshi Nakamizo; Teruasa Murata; Yuri Ueharaguchi-Tanada; Sachiko Ono; Wataru Amano; Saeko Nakajima; Gyohei Egawa; Hideaki Tanizaki; Atsushi Otsuka; Akihiko Kitoh; Teruki Dainichi; Narihito Ogawa; Yuichi Kobayashi; Takehiko Yokomizo; Makoto Arita; Motonobu Nakamura; Yoshiki Miyachi; Kenji Kabashima
Sawada et al. report that Resolvin E1 (RvE1) down-regulates DC motility in both steady state and inflammatory conditions in the skin and exerts its antiinflammatory effects in contact hypersensitivity. They propose the LTB4-BLT1 signaling blockade as a possible major mechanism through which RvE1 exerts its regulatory effects.
Journal of Dermatological Science | 2014
Teruki Dainichi; Sho Hanakawa; Kenji Kabashima
The host defense system of the skin is composed of (1) a barrier, (2) innate immunity, and (3) acquired immunity. Inflammatory skin diseases can be classified into one of the disorders of these layers of the defense system, unless there is an ordinary response to specific infectious agents or internal/external injury. Any inflammatory skin disease partly simulates the response to real infections or dangers. Disorders of acquired immunity can be classified into (1) immunodeficiency, (2) immunohyperactivity (allergy), and (3) qualitative disorder (autoimmunity). Disorders of innate immunity can be classified into (1) innate immunodeficiency, (2) innate immunohyperactivity (general or local autoinflammation), and (3) qualitative disorder (general or local innate autoimmunity). The barrier of the skin is composed of (1) the physical barrier and (2) the chemical barrier. Several diseases, such as atopic dermatitis, are attributed to the disorder of these components of the barrier. Here, we propose an algorithm to classify the pathology of inflammatory skin diseases by means of what disorder in the specific layer of the host defense system is truly responsible.
Experimental Dermatology | 2015
Kazunari Sugita; Sho Hanakawa; Tetsuya Honda; Gen Kondoh; Yoshiki Miyachi; Kenji Kabashima; Takashi Nomura
Helios is a member of the Ikaros transcription factor family and has been reported to be a marker of thymus‐derived regulatory T cells (Treg). Helios is an intracellular protein, however, and hence cannot be used as a marker to separate living Tregs. To solve this problem, we generated Helios reporter mice in which Helios+ cells selectively express Venus, a variant of green fluorescent protein. Most of the Tregs in the thymus expressed Helios, whereas its expression was varied in peripheral lymphoid organs. The Helios+ Treg‐population was superior in ability to suppress both antigen‐specific and TCR‐stimulated T cell responses. We also showed that Helios+ Tregs inhibited the cytokine production by T cells more efficiently than Helios‐ Tregs. We conclude that Helios reporter mouse strain is a useful tool to study function of Helios and that Helios+ Tregs represent the highly suppressive population.
The Journal of Allergy and Clinical Immunology | 2018
Yuri Ueharaguchi; Tetsuya Honda; Nobuhiro Kusuba; Sho Hanakawa; Akimasa Adachi; Yu Sawada; Atsushi Otsuka; Akihiko Kitoh; Teruki Dainichi; Gyohei Egawa; Chisa Nakashima; Saeko Nakajima; Teruasa Murata; Sachiko Ono; Makoto Arita; Shuh Narumiya; Yoshiki Miyachi; Kenji Kabashima
Thromboxane A2-TP signaling facilitates IL-17A production from dermal Vγ4+ γδ T cells and promotes psoriatic dermatitis in mice. Regulation of TP activation may become a novel therapeutic target for psoriasis.
The Journal of Allergy and Clinical Immunology | 2013
Atsushi Otsuka; Sho Hanakawa; Yoshiki Miyachi; Kenji Kabashima
Journal of Dermatological Science | 2017
Sho Hanakawa; Akihiko Kitoh; Kenji Kabashima
Journal of Dermatological Science | 2016
Kazutoshi Saito; Akihiko Kitoh; Sho Hanakawa; Takashi Nomura; Yoshiki Miyachi; Kenji Kabashima